Waning Immunity to Pertussis Following 5 Doses of DTaP

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pediatrics

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2012-1928PMID 23478868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress in Immunization Information Systems — United States, 2011

  2013cited by this paper
• Pertussis epidemic--Washington, 2012.

  2012cited by this paper
• Early Impact of the US Tdap vaccination program on pertussis trends.

  2012cited by this paper
• Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009

  2012cited by this paper
• Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.

  2012cited by this paper
• Waning protection after fifth dose of acellular pertussis vaccine in children.

  2012cited by this paper
• California pertussis epidemic, 2010.

  2012cited by this paper
• Summary of notifiable diseases--United States, 2010.

  2012cited by this paper
• Leveraging State Immunization Information Systems to Measure the Effectiveness of Rotavirus Vaccine

  2011cited by this paper
• Vaccination coverage among children in kindergarten--United States, 2009-10 school year.

  2011cited by this paper
• Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008.

  2011cited by this paper
• Summary of notifiable diseases: United States, 2009.

  2011cited by this paper
• The use of immunization registry-based data in vaccine effectiveness studies.

  2011cited by this paper
• Progress in immunization information systems --- United States, 2009.

  2011cited by this paper
• The "meaningful use" regulation for electronic health records.

  2010cited by this paper
• Progress in Immunization Information Systems — United States, 2012

  2010cited by this paper
• Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children.

  2010cited by this paper
• Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2009cited by this paper
• Burden of Acute Gastroenteritis Hospitalizations and Emergency Department Visits in US Children That Is Potentially Preventable by Rotavirus Vaccination: A Probe Study Using the Now-Withdrawn RotaShield Vaccine

  2009cited by this paper
• Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence

  2009cited by this paper
• Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003–2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children

  2007cited by this paper
• Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.

  2006cited by this paper
• Pertussis Vaccine Effectiveness Among Children 6 to 59 Months of Age in the United States, 1998–2001

  2005cited by this paper
• Effectiveness of pertussis vaccination in New South Wales, Australia, 1996–1998

  2004cited by this paper
• Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine

  2002cited by this paper
• Recommended childhood immunization schedule--United States, 2002.

  2002cited by this paper
• Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

  2001cited by this paper
• A ten year follow-up after immunization with a two component acellular pertussis vaccine.

  1999cited by this paper
• Recommended childhood immunization schedule--United States, 1997.

  1997cited by this paper
• Summary of Notifiable Diseases, United States.

  1997cited by this paper
• Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  1997cited by this paper
• A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal.

  1997cited by this paper
• Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  1996cited by this paper
• Logit-Based Interval Estimation for Binomial Data Using the Jeffreys Prior

  1987cited by this paper
• Symptoms after primary immunisation with DTP and with DT vaccine.

  1984cited by this paper
• DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose.

  1984cited by this paper
• Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

  1981cited by this paper

• Analysis of Macrolide Resistance in Bordetella pertussis Isolated from Japanese Children in 2025 Using Test Kit and Sequence Method

  2026cites this paper
• Emerging novel methodologies to understand and strategically target long-lived plasma cells in vaccine design to induce durable immunity.

  2026cites this paper
• Pertussis—A Re-Emerging Threat Despite Immunization: An Analysis of Vaccine Effectiveness and Antibiotic Resistance

  2025influential citation
• Transplacental transfer of antibodies against pertussis and respiratory syncytial virus and follow-up after birth.

  2025cites this paper
• Immunization information systems’ implementation and characteristics across the world: a systematic review of the literature

  2025cites this paper
• Resurgence of pertussis: whopping the ‘100-day cough’

  2025cites this paper
• Seroprevalence of tetanus and pertussis antibodies among health care workers in Wuhu, China

  2024cites this paper
• Comparison of Bordetella species identification among differing rt-PCR assays in the United States

  2024cites this paper
• Mechanisms and Implications of IgG4 Responses to SARS-CoV-2 and Other Repeatedly Administered Vaccines.

  2024cites this paper
• Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.

  2024cites this paper
• Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review.

  2023cites this paper
• High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation – United States, 2015–2017

  2023cites this paper
• The Decay of Pertussis Antibodies in Children Aged 0–14 Years in Jiangsu Province, China

  2023cites this paper
• Antibody and B-cell immune responses against Bordetella pertussis following infection and immunization.

  2023cites this paper
• Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network study.

  2023cites this paper
• Immunological aspects of additional revaccination of adolescents against whooping cough, diphtheria and tetanus

  2023cites this paper
• Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases

  2023cites this paper
• Pertussis in India: Past, Present, and Future

  2022cites this paper
• Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice

  2022cites this paper
• Spatiotemporal analysis of pertussis in Hunan Province, China, 2009–2019

  2022cites this paper
• Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.

  2022cites this paper
• Pertussis seroprevalence among adults of reproductive age (20–39 years) in fourteen European countries

  2021cites this paper
• Community-Acquired Pneumonia in Childhood

  2021cites this paper
• Vaccines: A Clinical Overview and Practical Guide

  2021cites this paper
• Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.

  2021cites this paper
• Long-term analysis of pertussis vaccine immunity uncovers a memory B cell response to whole cell pertussis immunization that is absent from acellular immunized mice

  2021cites this paper
• Pertussis vaccines and the role of Bordetella pertussis lipooligosaccharide in the immune response to pertussis infection and vaccination

  2021cites this paper
• Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness

  2021cites this paper
• Waning immunity after receipt of Pertussis, Diphtheria, Tetanus and Polio-related vaccines: a systematic review and meta-analysis.

  2021cites this paper
• Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis

  2021cites this paper
• Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes

  2021cites this paper
• Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.

  2020cites this paper
• Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice

  2020cites this paper
• Vaccine-Preventable Disease Outbreaks

  2020cites this paper
• Evaluation of immunisation strategies for pertussis vaccines in Jinan, China – an interrupted time-series study

  2020cites this paper
• Chemical Synthesis and Immunological Evaluation of Pertussis-Like Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine.

  2020cites this paper
• Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand.

  2020cites this paper
• Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.

  2019cites this paper
• Spatio-temporal comparison of pertussis outbreaks in Olmsted County, Minnesota, 2004–2005 and 2012: a population-based study

  2019cites this paper
• Pertussis seroimmunity in mother-neonate pairs and other pediatric age groups from Egypt

  2019cites this paper
• Trends and Characteristics of Proposed and Enacted State Legislation on Childhood Vaccination Exemption, 2011-2017.

  2019cites this paper
• Toward a Controlled Human Infection Model of Pertussis.

  2019cites this paper
• Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study.

  2019cites this paper
• Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.

  2019cites this paper
• New Pertussis Vaccines: A Need and a Challenge.

  2019cites this paper
• Empfehlungen der STIKO – Was gibtʼs Neues?

  2019cites this paper
• DTaP Effectiveness: Not Perfect, But Still Good

  2019cites this paper
• Role of Evolutionary Selection Acting on Vaccine Antigens in the Re-Emergence of Bordetella Pertussis

  2019cites this paper
• Acellular Pertussis Vaccine Effectiveness Over Time

  2019cites this paper
• Bordetella pertussis isolates vary in their interactions with human complement components

  2018cites this paper
• The impact of past vaccination coverage and immunity on pertussis resurgence

  2018cites this paper
• Prevention of pertussis: from clinical trials to Real World Evidence

  2018cites this paper
• Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies

  2018cites this paper
• Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation

  2018cites this paper
• Comment on “The impact of past vaccination coverage and immunity on pertussis resurgence”

  2018cites this paper
• Prevention of pertussis: An unresolved problem

  2018cites this paper
• A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.

  2018cites this paper
• Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2018cites this paper
• Bordetella pertussis and Bordetella bronchiseptica filamentous hemagglutinins are processed at different sites

  2018cites this paper
• Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel?

  2018cites this paper
• Immunization documentation practices and vaccine-preventable disease surveillance capacity among institutions of higher education in Indiana

  2018cites this paper
• The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.

  2018cites this paper
• Approximating instantaneous vaccine efficacy from cumulative vaccine efficacy

  2018cites this paper
• Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance

  2018cites this paper
• Rethinking the efficacy of acellular pertussis vaccines for primary immunization

  2018cites this paper
• Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization

  2018cites this paper
• Preventive and Protective Properties of Pertussis Vaccines: Current Situation and Future Challenges

  2018cites this paper
• Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.

  2018cites this paper
• A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.

  2018cites this paper
• Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study

  2018cites this paper
• Assessment of Tdap Vaccination Effectiveness in Adolescents in Integrated Health-Care Systems.

  2018cites this paper
• Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.

  2018cites this paper
• Marked Underreporting of Pertussis Requiring Hospitalization in Infants as Estimated by Capture–Recapture Methodology, Germany, 2013–2015

  2018cites this paper
• Composition of pertussis vaccine given to infants determines long-term T cell polarization

  2018cites this paper
• Pertussis-like syndrome in primary care practice

  2017cites this paper
• How well do ICD-9 physician claim diagnostic codes identify confirmed pertussis cases in Alberta, Canada? A Canadian Immunization Research Network (CIRN) Study

  2017cites this paper
• A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses

  2017cites this paper
• Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States

  2017cites this paper
• Immune persistence after pertussis vaccination

  2017cites this paper
• Immunization against Pertussis: An Almost Solved Problem or a Headache in Public Health

  2017cites this paper
• Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.

  2017cites this paper
• The BvgAS Regulon of Bordetella pertussis

  2017cites this paper
• Effects of California Assembly Bill 2109 in Low Vaccination Rate Counties: Are We Looking at the Right Variables?

  2017cites this paper
• An Indian Perspective of Some Recent Developments in Polio, DPT, Zika and Rotavirus Vaccines

  2017cites this paper
• Estimating Pertussis Susceptibility Among 0–23-Month-Old Children in the United States: Using National Immunization Survey (NIS) 2013

  2017cites this paper
• Increasing Incidence of Life-threatening Pertussis: A Retrospective Cohort Study in New Zealand

  2017cites this paper
• Use of acellular pertussis vaccines in the United States: can we do better?

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.

  2017cites this paper
• Control selection and confounding factors: A lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness.

  2017cites this paper
• Impfprävention – Empfehlungen und aktuelle Daten

  2017cites this paper
• Incorporating the Centers for Disease Control and Prevention into Vaccine Pricing Models

  2017cites this paper
• Is “Delitigation” Associated with a Change in Product Safety? The Case of Vaccines

  2017cites this paper
• Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007–2014

  2017cites this paper
• Vaccine Science and Immunization Guideline

  2017cites this paper
• Pertussis Persistence in Ontario

  2017cites this paper
• What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

  2017cites this paper
• Risk factors for pertussis in adults and teenagers in England

  2017cites this paper
• Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.

  2017cites this paper
• Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases

  2017cites this paper
• Vaccine-Preventable Diseases and the Vaccines That Prevent Them

  2017cites this paper